Increase in E. active rosette forming lymphocytes in melanoma patients treated with BCG.
D001500:BCG Vaccine / Q000494:pharmacology* / Q000627:therapeutic use; D006801:Humans; D008545:Melanoma / Q000276:immunology / Q000628:therapy*; D013601:T-Lymphocytes / Q000276:immunology*
D001500:BCG Vaccine